AzTrials
AzTrials

Airway Complication of AnaesthesiaPhase 4NCT01491984

Effectiveness and Safety of the Levitan Scope for Laryngoscopy and Tracheal Intubation With a Simulated Difficult Airway

A Phase 4 study testing Laryngoscopy order: 1) MAC, 2) Levitan and Laryngoscopy order: 1) Levitan, 2) MAC in people with Airway Complication of Anaesthesia, run by IWK Health Centre.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A laryngoscope is a medical instrument that is used to get a view of the voice box and the space in between the vocal cords. A laryngoscope is used to place a breathing tube into the trachea (windpipe or airway) to protect the patient's airway and provide a way to help a person breathe during surgery; this is called… Read more about this study

Who is it for?
Ages 16 to 75 years, women only
Conditions the study is for
Airway Complication of Anaesthesia
What is being tested?
Laryngoscopy order: 1) MAC, 2) Levitan and Laryngoscopy order: 1) Levitan, 2) MAC
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
105 participants
Where
No sites listed yet
Study dates
Jul 2009to Jul 2010
Phase
Phase 4
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 75 years
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists (ASA) physical status I or II (healthy or mild systemic disease, ex. asthma, high blood pressure)
  • Elective surgery requiring endotracheal intubation
  • English speaking
  • Age 16 - 75 years

Who cannot join

  • Significant gastroesophageal reflux disease (GERD) that may require alternate induction/intubation techniques
  • Prior history of a difficult intubation requiring an awake tracheal intubation
  • Clinical predictors of a potentially difficult intubation requiring an awake intubation
  • BMI > 45 kg/m2 (Obesity is a common and important risk factor for difficult intubation)

About this study

Official title: Effectiveness and Safety of the Levitan FPS Scope for Laryngoscopy and Tracheal Intubation With a Simulated Difficult Airway in Surgical Subjects Under General Anesthesia

A laryngoscope is a medical instrument that is used to get a view of the voice box and the space in between the vocal cords. A laryngoscope is used to place a breathing tube into the trachea (windpipe or airway) to protect the patient's airway and provide a way to help a person breathe during surgery; this is called intubation.

Read the detailed description

A laryngoscope is a medical instrument that is used to get a view of the voice box and the space in between the vocal cords. A laryngoscope is used to place a breathing tube into the trachea (windpipe or airway) to protect the patient's airway and provide a way to help a person breathe during surgery; this is called intubation. The placement of a breathing tube into the windpipe is a skill that is not easily mastered. In fact, the placement is difficult or impossible using the usual technique in 1-3 of every 100 patients. The ease of placing this breathing tube depends in part on how easily and how much of the vocal cords are able to be seen directly using a laryngoscope.

In a small number of patients, the Levitan First Pass Success (FPS) Scope has been shown to be more effective and easier to insert even in patients who have difficult airways. This study will evaluate the use of the LFS compared to the other conventional laryngoscope in subjects with a simulated difficult airway. The goal of this study is to determine the effectiveness and safety of the LFS in a large number of patients with simulated airway difficulties.

The results obtained during the study may provide useful information to health care providers who cannot place a breathing tube in patients that are either in operating rooms or in emergency situations requiring intubation by paramedics. An example would be a trauma situation where a paramedic is having difficulty attempting an intubation when a patients c-spine is being protected from any movements.

The LFS is an affordable and transportable device, which makes this an attractive asset for health providers in smaller community settings or in paramedic vehicles which may not have the capacity to stock or ability to afford a variety of different scopes and must choose a more limited selection.

Being tested
Laryngoscopy order: 1) MAC, 2) Levitan, Laryngoscopy order: 1) Levitan, 2) MAC

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laryngoscopy order: 1) MAC, 2) LevitanDevice

    Laryngoscopy with MAC, then Levitan

  • Laryngoscopy order: 1) Levitan, 2) MACDevice

    Laryngoscopy with Levitan, then MAC

Study groups in NCT01491984
Study groupRoleWhat they receive
Laryngoscopy order: 1) MAC, 2) LevitanExperimentalLevitan FPS Intubation
Receives: Device: Laryngoscopy order: 1) MAC, 2) Levitan; Device: Laryngoscopy order: 1) Levitan, 2) MAC
Laryngoscopy order: 1) Levitan, 2) MACExperimentalMacintosh Intubation
Receives: Device: Laryngoscopy order: 1) MAC, 2) Levitan; Device: Laryngoscopy order: 1) Levitan, 2) MAC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cormack-Lehane Grade

    The anesthesiologist graded the laryngeal view after induction of anesthesia using Cormack-Lehane Scale.

    Grade 1 = full view of glottis Grade 2a = partial view of glottis Grade 2b = Only posterior extremity of glottis seen or only arytenoid cartilages Grade 3 = Only epiglottis seen, none of glottis seen Grade 4 = Neither glottis nor epiglottis seen

    Measured: intraoperative

Secondary outcomes (3)
  1. Number of Intubation Attempts

    Number of intubation attempts was recorded after intubation was completed.

    Measured: intraoperative

  2. Operator Rating of Difficulty

    The attending anesthesiologist rated the difficulty in using each technique to intubate the larynx using an 11-point numeric rating scale and a 4-point visual rating scale.

    Measured: intraoperative

  3. Time to Successful Intubation

    Time to successful intubation was documented during the second laryngoscopy and defined as the time from the insertion of the Macintosh laryngoscope into the oral cavity to its removal.

    Measured: intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2011 (estimated)
  2. Study startJul 2009
  3. Primary completionJul 2010
  4. Study completionJul 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
105 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01491984
Sponsor's protocol ID
IWK-4668-2009
Other IDs
IWK REB 4668
Status last verified
Feb 2015
First submitted
12 Dec 2011
Last updated
10 Mar 2015
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Laryngoscopy order: 1) MAC, 2) Levitan and Laryngoscopy order: 1) Levitan, 2) MAC in people with Airway Complication of Anaesthesia, run by IWK Health Centre.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 10 Mar 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cormack-Lehane Grade (time frame: intraoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in